|1.||Personality Disorders (Personality Disorder)
|2.||Anxiety Disorders (Anxiety Disorder)
|3.||Mental Disorders (Mental Disorder)
|4.||Psychotic Disorders (Schizoaffective Disorder)
|5.||Schizophrenia (Dementia Praecox)
|1.||D'Arcy, Carl: 2 articles (12/2012 - 07/2012)|
|2.||Yu, Yaqin: 2 articles (12/2012 - 07/2012)|
|3.||Yu, Qiong: 2 articles (12/2012 - 07/2012)|
|4.||Xie, Bing: 2 articles (12/2012 - 07/2012)|
|5.||Kou, Changgui: 2 articles (12/2012 - 07/2012)|
|6.||Meng, Xiangfei: 2 articles (12/2012 - 07/2012)|
|7.||Shi, Jieping: 2 articles (12/2012 - 07/2012)|
|8.||Suzuki, Takefumi: 2 articles (05/2009 - 10/2003)|
|9.||Yagi, Gohei: 2 articles (05/2009 - 10/2003)|
|10.||Watanabe, Koichiro: 2 articles (05/2009 - 10/2003)|
04/01/1988 - "Large scale trials in the neuroses indicate that benzodiazepines are ineffective in depression, and transiently and partially effective in anxiety. "
05/13/1982 - "The anxiolytic activity of a new benzodiazepine derivative, bomazepam, was investigated in 30 ambulatory patients treated for psychotic or neurotic disorders. "
05/01/2009 - "Since the literature on benzodiazepine use in elderly patients with anxiety disorders is limited, a large cross-sectional review of psychotropic prescriptions in 796 patients with neurotic disorders (ICD-10) (age range=11-91 years) was conducted across 30 sites in Japan. "
05/01/2011 - "The benzodiazepines became the most widely prescribed drugs worldwide, provided truly effective treatment for "minor forms" (neuroses) of mental disorders for the first time, increased the quality of scientific methodology in clinical research, and enabled the development of new etiopathogenic theories for anxiety disorders, especially after the discovery in 1977 of their high-affinity receptor complex."
11/01/1972 - "[Polygraphic studies of nocturnal sleep of subjects with phobic-obsessive neuroses treated with a new benzodiazepine (RO 5-3350)]."
|2.||Diazepam (Valium)FDA LinkGeneric
01/01/1989 - "1. The therapeutic efficacy on several neuroses between CM6912 and diazepam (DZP) was comparatively investigated by means of intergroup comparison method in a double-blind trials. "
05/01/1989 - "[Intro- and extraversion in patients with neuroses as factors differentiating the effect of diazepam on psychomotor function]."
11/01/1988 - "[Effect of diazepam on cognitive and psychomotor functions in patients with neuroses in relation to various anxiety levels]."
09/01/1988 - "[Age and sex of patients with neuroses as the factors differentiating the effect of diazepam doses on the psychomotor efficiency]."
09/01/1986 - "[Diazepam and reaction time in patients with neuroses]."
|4.||Acetylcholine (Acetylcholine Chloride)FDA Link
01/01/1986 - "Comparison of the clinical findings with the results of dynamic assays for peripheral levels of acetylcholine and catecholamine in dogs exposed to special psychogenic and physiogenic impacts has helped to form an understanding about some common mechanisms of the formation of neuroses and neurosis-like states. "
06/26/1954 - "Intravenous acetylcholine in treatment of the neuroses."
01/01/1986 - "Interaction between the clinical, EEG-effects and phenazepam concentration in the blood was studied in 111 patients with neurotic disorders after intake of the test drug dose (2 mg) administered singly and on the 14th day of the treatment. "
01/01/1989 - "Combined therapy of neurotic disorders is most effective with tranquilizers (phenazepam, nitrazepam, radedorm or éunoktin)."
|7.||Levodopa (L Dopa)FDA LinkGeneric
05/01/1983 - "Evaluation of various specific types of sympathoadrenal system responses to the L-DOPA administration as compared with healthy persons as well as evaluation of the response types characteristic for individual syndromes, improved the diagnostics of neuroses. "
05/01/1983 - "[Test with 0.1g L-DOPA in clinical neuroses and neurosis-like states]."
05/01/1983 - "Effect of a test with administration of 0.1 g L-DOPA, reflecting the synthetic processes in sympathoadrenal system and its reactivity, on dynamics of catecholamine and DOPA excretion with urine was studied in patients with neuroses and neurosis-like states, namely, in women with climacteric syndrome, in men with sexual deteriorations, in patients with general neuroses and in patients with initial manifestations of brain circulation insufficiency. "
|9.||Chlorpromazine (Thorazine)FDA Link
11/01/1957 - "[Electroencephalographic studies in certain neuroses during the improvement of the higher nervous activity induced by largactil]."
01/09/1971 - "[Pituitary gonadotropic activity in women with climacteric neuroses under chlorpromazine therapy]."
01/26/1957 - "Observations on the use of Largactil in psychoneuroses."
01/01/1956 - "[Effect of largactil on autnomic nervous functions in psychoneuroses]."
01/01/1956 - "[Chlorpromazine treatment in preparation of psychotherapy in neuroses]."
|10.||Oxazepam (Serax)FDA LinkGeneric
04/15/1972 - "[Oxazepam in the treatment of neurotic disorders as well as in ambulatory detoxication treatment for alcoholics and polytoxicomaniacs]."
03/31/1971 - "[Analysis of the anxiety-suppressing and autonomic hyperreactivity-suppressing effects of Oxazepam in psychoneuroses]."
01/01/1968 - "[Trial of treatment with oxazepam in anxiety and depressive states in the course of neuroses and psychoses]."
10/01/1969 - "Oxazepam in psychoneuroses and "anxiety bound" psychoses."
01/01/1967 - "[Clinical evaluation of a benzodiazepine derivative (oxazepam) in neuroses]."
|3.||Ambulatory Care (Outpatient Care)
12/01/1986 - "[Chronification of neuroses--on the critical phase of the inpatient-ambulatory care transition]."
03/01/1973 - "[Incidence of functional and neurotic disorders in rural ambulatory care]."
08/01/2001 - "This study deals with the utilization of in- and outpatient care due to non-psychotic/non-organic disorders (ICD-9 300-307: neuroses, personality disorders, sexual disturbances, alcohol and substance dependencies, drug abuse and functional disorders). "
|4.||Drug Therapy (Chemotherapy)
11/01/1969 - "[Theoretical bases of the chemotherapy of neuroses]."
02/20/1968 - "[Drug therapy of neuroses]."
09/01/1965 - "[Drug therapy of neuroses]."
03/01/1965 - "CHEMOTHERAPY OF SYMPTOMS OF CHRONIC ANXIETY STATES AND OTHER NEUROTIC DISORDERS."
01/01/1963 - "PSYCHOTHERAPY AND PHARMACOTHERAPY OF NEUROSES."
01/01/1988 - "In contrast, neuroses produce symptoms which are quantitatively, rather than qualitatively different from normal experience and psychosurgery has no place in their treatment. "
05/01/1962 - "[Prefrontal lobotomy in the treatment of severe neuroses. "
07/01/1955 - "Orbital undercutting in the aged limited lobotomy in the treatment of psychoneuroses and depressions in elderly persons."
03/01/1955 - "Orbital undercutting in the treatment of psychoneuroses, depressions and senile emotional states; results of fractional lobotomy in the benign psychiatric disorders."
11/01/1954 - "Orbital undercutting in the treatment of psychoneuroses, depressions and senile emotional states; psychiatric and physiologic results of fractional lobotomy in the milder emotional illnesses."